Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
SGLT2 inhibitor
Fluoroquinolone; topoisomerase IV and bacterial...
Anthracycline, DNA intercalator; topoisomerase ...
Cyclic hexapeptide isolated from Phomopsis lept...
NSAID; COX-1/2 inhibitor.
Nucleoside (deoxycytidine) analog; DNMT inhibit...
Adenosine A2A agonist.
OVA antigen.
Coccidiostat; dihydrofolate reductase inhibitor...
BK K+ channel and L-type Ca2+ channel blocker.<...
Tropane alkaloid found in Solanaceae plants; M1...
Polyphenol derivative of caffeic acid found in ...
Neuraminidase inhibitor.
AurKA/B inhibitor.
PORCN inhibitor.
Synthetic derivative of vasicine, mucolytic.
Stearoyl-coA desaturase 1 inhibitor.
Histamine H2 inverse agonist.
Imidazole; 14-α demethylase inhibitor, potenti...
ALK and IGF-1R inhibitor.